| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.47B | 1.39B | 1.40B | 1.44B | 1.86B | 2.10B |
| Gross Profit | 205.44M | 192.72M | 203.27M | 180.68M | 233.30M | 261.47M |
| EBITDA | 73.49M | 78.69M | 87.63M | 116.68M | 123.46M | 141.48M |
| Net Income | 32.43M | 34.40M | 32.06M | 59.81M | 56.47M | 79.27M |
Balance Sheet | ||||||
| Total Assets | 1.17B | 1.08B | 1.08B | 1.23B | 1.33B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 249.13M | 280.32M | 161.93M | 138.25M | 141.75M | 127.98M |
| Total Debt | 4.93M | 5.97M | 46.15M | 139.09M | 208.95M | 148.09M |
| Total Liabilities | 370.57M | 295.31M | 296.06M | 426.83M | 523.30M | 524.45M |
| Stockholders Equity | 793.08M | 786.05M | 780.99M | 802.62M | 808.44M | 800.97M |
Cash Flow | ||||||
| Free Cash Flow | 6.83M | 174.82M | 154.54M | 87.00M | 2.69M | -31.20M |
| Operating Cash Flow | 18.40M | 189.45M | 162.43M | 95.45M | 50.48M | 56.60M |
| Investing Cash Flow | -13.88M | -3.31M | -6.38M | 6.00M | -54.40M | -88.12M |
| Financing Cash Flow | -35.21M | -63.13M | -130.33M | -102.17M | 17.12M | 17.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$31.79B | 10.34 | 17.01% | 2.96% | 15.36% | 42.66% | |
66 Neutral | HK$307.57M | 7.61 | 4.11% | 7.62% | 25.54% | 17.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | HK$548.76B | 13.66 | 13.50% | ― | 12.77% | 14.09% | |
54 Neutral | HK$255.50M | -3.92 | -11.38% | 8.70% | -14.71% | 37.97% | |
43 Neutral | HK$232.35M | -2.49 | -13.04% | ― | -45.30% | 53.12% |